Women's Health

BALTIMORE — A special late-breaking session at the ACOG Annual Scientific & Clinical meeting featured the most up-to-date information and guidance on availability of the abortion drug mifepristone.

People who experience adverse pregnancy outcomes develop cerebrovascular disease at younger ages, with the earliest onset and greatest risk seen in those with multiple pregnancies affected by complications, researchers reported.

BALTIMORE — A one-time dose of off-label cabergoline after second-trimester abortion or pregnancy loss was effective for preventing symptomatic breast engorgement, according to data presented at the ACOG Annual Clinical & Scientific Meeting.

BALTIMORE — Patients with heavy menstrual bleeding who received the levonorgestrel 52 mg intrauterine device experienced significant and rapid decreases in uterine bleeding after placement, a researcher reported here.

BALTIMORE — Instagram is being used to distribute accurate and inaccurate medical information about abortion by both medical and nonmedical professionals, researchers reported at the ACOG Annual Clinical & Scientific Meeting.

For National Women’s Health Week, Healio Editors compiled news on pregnancy.

The ACOG Annual Clinical & Scientific Meeting will have a heavy focus on overcoming current challenges, including diversity, equity and inclusion, in women’s health.

The Healio Editors compiled news on osteoporosis in women’s health for National Women’s Health Week.

Risk for type 2 diabetes with use of menopausal hormone therapy varied by type of HT, according to a retrospective cohort study of women in South Korea published in Menopause.

Among people aged 55 years or older who had a high burden of coronary atherosclerosis, women were at greater risk for a major adverse cardiovascular event than men, researchers reported.